Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Vitrolife hits bottom of STOXX as Q4 margin comes under pressure

** Shares in Vitrolife  VITR.ST  plummet about 10% to nearly
eight-month low after the Swedish medical technology group's
margin declined in the final quarter  urn:newsml:reuters.com:*:nFWN2UR0MC   
    ** The company posts Q4 EBITDA margin of 16% versus 43%
reported a year ago
    ** "Most or all companies with a relatively high valuation
tend to be exposed when organic growth is temporary under
pressure. Especially when this also goes for the margins,"
Redeye analyst Johan Unnerus says
    ** The stock is bottom performer on STOXX 600  .STOXX 
index, down over 38% year-to-date


 (Reporting by Marta Frackowiak)
 ((marta.frackowiak@thomsonreuters.com))

Recent news on Vitrolife AB

See all news